TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,078,987 | -52.3% | 134,388 | -51.5% | 0.20% | +2.6% |
Q2 2023 | $4,354,426 | +88.6% | 277,176 | +97.9% | 0.20% | -8.4% |
Q1 2023 | $2,308,580 | -47.5% | 140,084 | -50.3% | 0.21% | +6.5% |
Q4 2022 | $4,397,006 | +291.5% | 281,860 | +225.5% | 0.20% | +81.1% |
Q3 2022 | $1,123,000 | -43.1% | 86,581 | -38.4% | 0.11% | -42.2% |
Q2 2022 | $1,972,000 | -6.8% | 140,444 | -4.9% | 0.19% | -2.5% |
Q1 2022 | $2,115,000 | +224.4% | 147,692 | +208.6% | 0.20% | +233.9% |
Q4 2021 | $652,000 | – | 47,852 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |